GDS Wealth Management Purchases 2,970 Shares of STERIS plc $STE

GDS Wealth Management increased its position in shares of STERIS plc (NYSE:STE) by 4.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 68,667 shares of the medical equipment provider’s stock after acquiring an additional 2,970 shares during the quarter. GDS Wealth Management owned about 0.07% of STERIS worth $16,991,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in STE. Steigerwald Gordon & Koch Inc. bought a new stake in STERIS during the 3rd quarter worth about $25,000. Spurstone Advisory Services LLC acquired a new stake in shares of STERIS during the 2nd quarter worth approximately $29,000. Geneos Wealth Management Inc. raised its stake in shares of STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 104 shares during the last quarter. TruNorth Capital Management LLC acquired a new position in STERIS in the third quarter valued at approximately $37,000. Finally, Root Financial Partners LLC bought a new position in STERIS in the third quarter valued at approximately $39,000. Institutional investors own 94.69% of the company’s stock.

Insider Transactions at STERIS

In other STERIS news, VP John Adam Zangerle sold 15,000 shares of STERIS stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total value of $3,977,100.00. Following the transaction, the vice president owned 33,669 shares of the company’s stock, valued at approximately $8,926,998.66. The trade was a 30.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP Renato Tamaro sold 5,036 shares of the company’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total transaction of $1,297,021.80. Following the completion of the transaction, the vice president owned 5,695 shares of the company’s stock, valued at $1,466,747.25. This trade represents a 46.93% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 25,044 shares of company stock valued at $6,586,218 over the last 90 days. 1.07% of the stock is owned by company insiders.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Seven investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $273.50.

STERIS Stock Down 0.6%

Shares of NYSE:STE opened at $259.44 on Friday. The company has a 50 day moving average price of $258.84 and a two-hundred day moving average price of $247.57. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.63 and a current ratio of 2.37. The company has a market capitalization of $25.46 billion, a PE ratio of 37.28 and a beta of 1.03. STERIS plc has a 52 week low of $204.90 and a 52 week high of $269.44.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.09. STERIS had a net margin of 12.07% and a return on equity of 14.43%. The company had revenue of $1.46 billion for the quarter, compared to analysts’ expectations of $1.43 billion. During the same period last year, the firm posted $2.14 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th were issued a $0.63 dividend. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date was Tuesday, November 18th. STERIS’s dividend payout ratio is 36.21%.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.